Learning Objectives:

1. Discussing dual antiplatelet therapy after PCI in high bleeding risk patient

2. Assessing safety of one-month dual antiplatelet therapy in high bleeding risk patients 

3. Assessing bleeding risk with abbreviated dual anti platelet therapy 

Session date: 
12/17/2021 - 7:30am to 8:30am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Iva Minga, MD